Delivery Order SPE2DB20D2104-SPE2DB22FR51G
- Not listed
- This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA). The $1,955.99 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,635.20 and an ultimate completion date of December 7, 2022. The contract was awarded on December 6, 2022 and does not have a set-aside...
- This federal contract award is for the delivery of 4,559,457,678 units of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA). The $1,573.55 fixed-price delivery order was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 28, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $2,019.23 to supply Oseltamivir Phosphate 75 mg capsules to support military treatment programs and facilities. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,323.66 firm fixed-price delivery order is for the supply of 4,563,755,824 units of the drug Oseltamivir Phosphate 45 mg capsules. The contract has an ultimate completion date of February 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This contract award is for the delivery of 4,563,518,552 capsules of the pharmaceutical drug Oseltamivir Phosphate 75 mg to the Defense Logistics Agency (DLA). The $7,193.69 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 1, 2024. The contract has a period of performance through February 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a ceiling value of $1,703.80 and a performance period through March 19, 2024. It is not associated with any set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oseltamivir Phosphate 75 mg capsules. The contract has a ceiling value of $6,654.26 and is structured as a Firm Fixed Price Delivery Order. It does not utilize a set-aside designation. Amerisourcebergen is the prime contractor and will be responsible for providing the specified pharmaceutical product to support the DLA's medical...
- This federal contract award, valued at $12,975.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,559,450,627 units of Oseltamivir Phosphate 75 mg capsules, which are used to treat influenza. The contract has an ultimate completion date of December 27, 2022 and is structured as a firm fixed-price delivery order. There is no set-aside designation, indicating the contract was awarded through...
- This federal contract award is for the delivery of TAMIFLU 75 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $8,242.58 and has a completion date of September 28, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FR51GDelivery Order
This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $1,130.62, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 14, 2022. Amerisourcebergen Drug Corp is an experienced pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/13/22 |